Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Vitamin E539 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00050 | 35243111 | Transl Gastroenterol Hepatol | Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice. | 2022 | Details |
| A00271 | 35159219 | Cells | S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent. | 2022 | Details |
| A00446 | 35080048 | J Gastroenterol Hepatol | Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A00543 | 35052573 | Antioxidants (Basel) | Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig. | 2021 | Details |
| A00759 | 34977520 | JHEP Rep | Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. | 2021 | Details |
| A00767 | 34974285 | Nutrition | Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis. | 2021 | Details |
| A00959 | 34918671 | Medicine (Baltimore) | Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States. | 2021 | Details |
| A01100 | 34869532 | Front Nutr | Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults. | 2021 | Details |
| A01155 | 34850615 | Clin Chem Lab Med | Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease. | 2021 | Details |
| A01269 | 34808388 | Bioorg Med Chem Lett | Design, synthesis and activity evaluation of prodrug form JBP485 and Vitamin E for alleviation of NASH. | 2021 | Details |
| A01403 | 34758930 | Arch Pediatr | The role of nutrition in non-alcoholic fatty liver disease treatment in obese children. | 2021 | Details |
| A01468 | 34736591 | Pediatr Clin North Am | Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01511 | 34715296 | Free Radic Biol Med | Role of vitamin E in the treatment of non-alcoholic steatohepatitis. | 2021 | Details |
| A01564 | 34692725 | Front Med (Lausanne) | PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2021 | Details |
| A01575 | 34688168 | Curr Opin Pharmacol | Non-alcoholic fatty liver disease: Current therapeutic options. | 2021 | Details |
| A01890 | 34572279 | Biomedicines | Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States. | 2021 | Details |
| A02002 | 34533632 | J Gastroenterol | Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. | 2021 | Details |
| A02004 | 34533266 | Hepatol Res | Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. | 2021 | Details |
| A02006 | 34533249 | Phytother Res | The effects of co-administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trial. | 2021 | Details |
| A02042 | 34522493 | Cureus | The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A02124 | 34497708 | Ther Adv Endocrinol Metab | Therapeutic approaches for non-alcoholic steatohepatitis. | 2021 | Details |
| A02220 | 34455040 | Free Radic Biol Med | Mitochondrial dysfunction in mouse livers depleted of iron chaperone PCBP1. | 2021 | Details |
| A02287 | 34435378 | Aliment Pharmacol Ther | Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH. | 2021 | Details |
| A02349 | 34406410 | J Clin Endocrinol Metab | The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD. | 2022 | Details |
| A02370 | 34400208 | J Pediatr | Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin. | 2021 | Details |
| A02620 | 34307250 | Front Pediatr | Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2021 | Details |
| A02694 | 34280304 | Cochrane Database Syst Rev | Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A02844 | 34221537 | Liver Res | Vitamins and non-alcoholic fatty liver disease: A Molecular Insight⋆. | 2021 | Details |
| A02873 | 34210457 | Rev Gastroenterol Mex (Engl Ed) | Dietary and sociodemographic factors associated with nonalcoholic fatty liver in obese pediatric patients. | 2021 | Details |
| A02978 | 34176419 | Expert Rev Gastroenterol Hepatol | Chronic liver disease and oxidative stress - a narrative review. | 2021 | Details |
| A03076 | 34139927 | Pharm Biol | Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1) via restoring the balance of intestinal flora in rats. | 2021 | Details |
| A03173 | 34101924 | Biofactors | alpha-Tocopherol supplementation reduces inflammation and apoptosis in high cholesterol mediated nonalcoholic steatohepatitis. | 2021 | Details |
| A03254 | 34069568 | Nutrients | Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status. | 2021 | Details |
| A03367 | 34027269 | Hepatol Commun | Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. | 2021 | Details |
| A03744 | 33879971 | J Clin Biochem Nutr | Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial. | 2021 | Details |
| A03805 | 33860119 | Hepatol Commun | Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver-Related Events in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04056 | 33773953 | Redox Biol | Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease. | 2021 | Details |
| A04061 | 33772908 | Biofactors | The role of biofactors in the prevention and treatment of age-related diseases. | 2021 | Details |
| A04063 | 33772456 | Indian J Gastroenterol | Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study. | 2021 | Details |
| A04068 | 33771699 | Pharmacol Res | Epigenetics in NAFLD/NASH: Targets and therapy. | 2021 | Details |
| A04130 | 33746449 | J Clin Exp Hepatol | What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease? | 2020 | Details |
| A04200 | 33718398 | Front Med (Lausanne) | Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. | 2021 | Details |
| A04272 | 33680496 | Obes Sci Pract | α-Tocopherol suppresses hepatic steatosis by increasing CPT-1 expression in a mouse model of diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A04309 | 33671262 | Nutrients | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model. | 2021 | Details |
| A04349 | 33652942 | Int J Mol Sci | Treatments for NAFLD: State of Art. | 2021 | Details |
| A04466 | 33604254 | J Clin Transl Hepatol | Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail. | 2020 | Details |
| A04829 | 33491528 | J Diet Suppl | The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease. | 2021 | Details |
| A04896 | 33461969 | BMJ | Management of non-alcoholic fatty liver disease. | 2021 | Details |
| A05080 | 33385317 | J Dig Dis | Efficacy and safety of drugs for nonalcoholic steatohepatitis. | 2021 | Details |
| A05216 | 33335561 | Therap Adv Gastroenterol | The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. | 2020 | Details |
| A05392 | 33272889 | Clin Res Hepatol Gastroenterol | Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis. | 2020 | Details |
| A05546 | 33212947 | Nutrients | Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05637 | 33179890 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management. | 2020 | Details |
| A05680 | 33162737 | Ann Gastroenterol | Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions. | 2020 | Details |
| A05751 | 33132645 | World J Gastroenterol | Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A05793 | 33115209 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming. | 2020 | Details |
| A05903 | 33080906 | Medicina (Kaunas) | Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients. | 2020 | Details |
| A05956 | 33061886 | Food Nutr Res | Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver disease. | 2020 | Details |
| A05964 | 33060043 | Dig Liver Dis | Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. | 2020 | Details |
| A06046 | 33029240 | Acta Endocrinol (Buchar) | THE EFFECTS OF REALSIL (SILYBIN-PHOSPHOLIPID-VITAMIN E COMPLEX) ON LIVER ENZYMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR NON-ALCOHOLIC STEATO-HEPATITIS (NASH): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS. | 2022 | Details |
| A06129 | 32995080 | PeerJ | Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study. | 2020 | Details |
| A06217 | 32964201 | JHEP Rep | The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. | 2020 | Details |
| A06255 | 32951743 | Complement Ther Med | Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2020 | Details |
| A06327 | 32927776 | Nutrients | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. | 2020 | Details |
| A06348 | 32920226 | Redox Biol | Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. | 2020 | Details |
| A06374 | 32908830 | Eur J Case Rep Intern Med | High-Titre ANA Positivity in NAFLD: An Uncommon Presentation of a Common Disease. | 2020 | Details |
| A06470 | 32867573 | J Histochem Cytochem | 4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept. | 2020 | Details |
| A06594 | 32814993 | Curr Gastroenterol Rep | Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06609 | 32810309 | J Gastroenterol Hepatol | Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06665 | 32789148 | Clin Nutr Res | Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. | 2020 | Details |
| A06679 | 32782954 | JGH Open | Effect of telmisartan and vitamin E on liver histopathology with non-alcoholic steatohepatitis: A randomized, open-label, noninferiority trial. | 2020 | Details |
| A06704 | 32775098 | Cureus | Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials. | 2020 | Details |
| A06938 | 32692879 | Mol Nutr Food Res | Inflammatory Diseases and Vitamin E-What Do We Know and Where Do We Go? | 2020 | Details |
| A06984 | 32673798 | Mol Metab | Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis. | 2020 | Details |
| A07066 | 32634622 | Clin Gastroenterol Hepatol | Real-World Burden of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07076 | 32630732 | Antioxidants (Basel) | Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women. | 2020 | Details |
| A07141 | 32605253 | Cancers (Basel) | Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07368 | 32524096 | Hawaii J Health Soc Welf | Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. | 2020 | Details |
| A07423 | 32506513 | J Gastroenterol Hepatol | Use of metabolic syndrome severity to assess treatment with vitamin E and pioglitazone for non-alcoholic steatohepatitis. | 2020 | Details |
| A07609 | 32424494 | Adv Exp Med Biol | Non-alcoholic Fatty Liver Disease and Diabetes Mellitus. | 2021 | Details |
| A07651 | 32408667 | Int J Environ Res Public Health | The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease. | 2020 | Details |
| A08128 | 32237916 | Expert Opin Pharmacother | Current and new pharmacotherapy options for non-alcoholic steatohepatitis. | 2020 | Details |
| A08235 | 32191400 | Clin Pharmacol Drug Dev | Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. | 2020 | Details |
| A08244 | 32189929 | J Clin Exp Hepatol | Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index. | 2019 | Details |
| A08288 | 32168769 | Int J Mol Sci | Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08327 | 32151660 | Metabolism | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08328 | 32151552 | Surg Obes Relat Dis | Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons. | 2020 | Details |
| A08498 | 32086244 | J Lipid Res | Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice. | 2020 | Details |
| A08701 | 32017891 | Am J Med | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? | 2020 | Details |
| A08784 | 31985850 | JPEN J Parenter Enteral Nutr | Identifying Predictors of Response to Vitamin E for the Treatment of Pediatric Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08937 | 31930901 | Zhongguo Zhen Jiu | [Mechanism of catgut embedding at back-shu points for nonalcoholic steatohepatitis based on IKK/IKB/NF-κB signaling pathway]. | 2020 | Details |
| A09047 | 31889754 | J Clin Exp Hepatol | Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09415 | 31757735 | Presse Med | [Pharmacological treatment of NASH]. | 2019 | Details |
| A09433 | 31752351 | Nutrients | Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model. | 2019 | Details |
| A09460 | 31737175 | Oxid Med Cell Longev | Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. | 2019 | Details |
| A09680 | 31651429 | AIDS | Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients. | 2020 | Details |
| A09715 | 31635468 | Vnitr Lek | Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10127 | 31474630 | Yakugaku Zasshi | [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management]. | 2019 | Details |
| A10204 | 31434683 | Postgrad Med J | Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A10342 | 31382287 | Ann Intern Med | How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. | 2019 | Details |